From Photostats to Home Pages on the World Wide Web: A Tutorial on How to Create Your Electronic Archive

It was Derek De Solla Price who in 1963 said that "80 to 90 percent of all the scientists that have ever lived are alive now."1 While De Solla died just 20 years later, most of his contemporaries have survived. A majority of these researchers were, at one time or another, readers of Current Contents (CC). The success of CC was due to three critical factors--timeliness, its multidisciplinary nature, and access to author addresses. Its address directory was estimated at one time to generate as

Written byEugene Garfield
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

It was Derek De Solla Price who in 1963 said that "80 to 90 percent of all the scientists that have ever lived are alive now."1 While De Solla died just 20 years later, most of his contemporaries have survived. A majority of these researchers were, at one time or another, readers of Current Contents (CC).

The success of CC was due to three critical factors--timeliness, its multidisciplinary nature, and access to author addresses. Its address directory was estimated at one time to generate as many as 15 million reprint requests per year.2 The large-scale exchange of reprints has become an almost bygone culture. Widely available document delivery mechanisms and increasingly, the World Wide Web, have displaced routine requests for reprints. Nevertheless, many of us still enjoy the convenience of the reprint, and when possible, the pleasure of a note and autograph by the author.3

The reprint culture supported thousands ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies